Simplex Trading
TXG icon

Simplex Trading’s 10x Genomics TXG Stock Holding History

Simplex Trading’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Sell
10,200
-25,200
-71% -$660K ﹤0.01% 3918
2026
Q1 		$752K Buy
35,400
+25,300
+250% +$506K ﹤0.01% 2797
2025
Q4 		$165K Sell
10,100
-164,200
-94% -$2.48M ﹤0.01% 4431
2025
Q3 		$2.04M Buy
174,300
+160,500
+1,163% +$2.09M ﹤0.01% 2310
2025
Q2 		$159K Sell
13,800
-8,000
-37% -$72.9K ﹤0.01% 4752
2025
Q1 		$190K Buy
21,800
+17,800
+445% +$224K ﹤0.01% 4394
2024
Q4 		$57K Sell
4,000
-7,800
-66% -$123K ﹤0.01% 5749
2024
Q3 		$266K Sell
11,800
-6,700
-36% -$139K ﹤0.01% 4250
2024
Q2 		$359K Sell
18,500
-4,400
-19% -$115K ﹤0.01% 4022
2024
Q1 		$859K Sell
22,900
-33,700
-60% -$1.48M ﹤0.01% 3285
2023
Q4 		$3.17M Sell
56,600
-148,500
-72% -$6.46M ﹤0.01% 1948
2023
Q3 		$8.46M Buy
205,100
+176,500
+617% +$9.18M 0.01% 1007
2023
Q2 		$1.6M Sell
28,600
-18,600
-39% -$1.01M ﹤0.01% 2162
2023
Q1 		$2.63M Buy
47,200
+43,700
+1,249% +$2.04M ﹤0.01% 1714
2022
Q4 		$127K Sell
3,500
-38,600
-92% -$1.26M ﹤0.01% 4788
2022
Q3 		$1.2M Buy
42,100
+34,600
+461% +$1.32M ﹤0.01% 2445
2022
Q2 		$339K Sell
7,500
-10,600
-59% -$550K ﹤0.01% 3941
2022
Q1 		$1.38M Buy
18,100
+12,400
+218% +$1.08M ﹤0.01% 2511
2021
Q4 		$849K Sell
5,700
-12,000
-68% -$1.84M ﹤0.01% 3085
2021
Q3 		$3.36M Hold
17,700
– – ﹤0.01% 1562
2021
Q2 		$3.47M Buy
17,700
+17,681
+93,058% +$3.2M ﹤0.01% 1527
2021
Q1 		$343K Sell
19
-350
-95% -$60.4K ﹤0.01% 3960
2020
Q4 		$5.22M Buy
369
+91
+33% +$13.2K 0.01% 959
2020
Q3 		$3.47M Sell
278
-12
-4% -$1.26K ﹤0.01% 1103
2020
Q2 		$2.59M Buy
290
+254
+706% +$19.8K ﹤0.01% 1307
2020
Q1 		$224K Buy
36
+19
+112% +$1.48K ﹤0.01% 3465
2019
Q4 		$129K Buy
+17
New +$1.02K ﹤0.01% 4238

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Simplex Trading's TXG Position: Q2 2026 in Review

Simplex Trading opened a new position in 10x Genomics (TXG) in Q2 2026: 51,807 shares worth $1.99M. The stake represents ﹤0.01% of the portfolio and ranks #2049 among its holdings. This is a return to the name: Simplex Trading previously reported a position in TXG as recently as Q4 2025.

Simplex Trading first reported a position in TXG in Q4 2019 and has held it in 13 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Simplex Trading held 51,807 shares of 10x Genomics worth $1.99M as of Q2 2026.
  • 10x Genomics was a new Simplex Trading position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #2049 holding.
  • Simplex Trading first reported a position in 10x Genomics in Q4 2019 and has held it in 13 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.